283 related articles for article (PubMed ID: 15818102)
61. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
Cook D; Heyland D; Griffith L; Cook R; Marshall J; Pagliarello J
Crit Care Med; 1999 Dec; 27(12):2812-7. PubMed ID: 10628631
[TBL] [Abstract][Full Text] [Related]
62. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
Lin HJ; Tseng GY; Hsieh YH; Perng CL; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 1999 Nov; 94(11):3184-8. PubMed ID: 10566712
[TBL] [Abstract][Full Text] [Related]
63. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.
Daneshmend TK; Hawkey CJ; Langman MJ; Logan RF; Long RG; Walt RP
BMJ; 1992 Jan; 304(6820):143-7. PubMed ID: 1737157
[TBL] [Abstract][Full Text] [Related]
64. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group.
López-Herce J; Dorao P; Elola P; Delgado MA; Ruza F; Madero R
Crit Care Med; 1992 Aug; 20(8):1082-9. PubMed ID: 1643886
[TBL] [Abstract][Full Text] [Related]
65. Control of gastric pH with cimetidine: boluses versus primed infusions.
Ostro MJ; Russell JA; Soldin SJ; Mahon WA; Jeejeebhoy KN
Gastroenterology; 1985 Sep; 89(3):532-7. PubMed ID: 4018499
[TBL] [Abstract][Full Text] [Related]
66. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
67. The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Canadian Critical Care Trials Group.
Heyland DK; Cook DJ; Schoenfeld PS; Frietag A; Varon J; Wood G
Crit Care Med; 1999 Nov; 27(11):2399-406. PubMed ID: 10579255
[TBL] [Abstract][Full Text] [Related]
68. Stress-related mucosal disease: incidence of bleeding and the role of omeprazole in its prophylaxis.
Amaral MC; Favas C; Alves JD; Riso N; Riscado MV
Eur J Intern Med; 2010 Oct; 21(5):386-8. PubMed ID: 20816590
[TBL] [Abstract][Full Text] [Related]
69. The potential clinical role of intravenous omeprazole.
Brunner GH; Thiesemann C
Digestion; 1992; 51 Suppl 1():17-20. PubMed ID: 1397742
[TBL] [Abstract][Full Text] [Related]
70. Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate.
Ryan P; Dawson J; Teres D; Celoria G; Navab F
Arch Surg; 1993 Dec; 128(12):1353-7. PubMed ID: 8250708
[TBL] [Abstract][Full Text] [Related]
71. A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Canoruç F
World J Gastroenterol; 2006 Dec; 12(48):7837-43. PubMed ID: 17203530
[TBL] [Abstract][Full Text] [Related]
72. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
73. Results of gastric neutralization with hourly antacids and cimetidine in 320 intubated patients with respiratory failure.
Khan F; Parekh A; Patel S; Chitkara R; Rehman M; Goyal R
Chest; 1981 Apr; 79(4):409-12. PubMed ID: 6971735
[TBL] [Abstract][Full Text] [Related]
74. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
[TBL] [Abstract][Full Text] [Related]
75. Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury.
Burgess P; Larson GM; Davidson P; Brown J; Metz CA
Dig Dis Sci; 1995 Mar; 40(3):645-50. PubMed ID: 7895560
[TBL] [Abstract][Full Text] [Related]
76. Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: a systematic review.
Reveiz L; Guerrero-Lozano R; Camacho A; Yara L; Mosquera PA
Pediatr Crit Care Med; 2010 Jan; 11(1):124-32. PubMed ID: 19770788
[TBL] [Abstract][Full Text] [Related]
77. Cimetidine vs antacid in prophylaxis for stress ulceration.
Weigelt JA; Aurbakken CM; Gewertz BL; Snyder WH
Arch Surg; 1981 May; 116(5):597-601. PubMed ID: 7016067
[TBL] [Abstract][Full Text] [Related]
78. [Recent progress in the drug therapy for gastrointestinal bleeding].
Nakajima S; Bamba T
Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
[TBL] [Abstract][Full Text] [Related]
79. Cimetidine versus antacids in the prevention of stress erosions in critically ill patients.
Poleski MH; Spanier AH
Am J Gastroenterol; 1986 Feb; 81(2):107-11. PubMed ID: 3946364
[TBL] [Abstract][Full Text] [Related]
80. Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients.
Sandborn WJ; Forland SC; Cutler RE; Strong RM
J Clin Pharmacol; 1990 Jun; 30(6):568-71. PubMed ID: 2355107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
